Zaleplon

This classification denotes a sedative and hypnotic with the molecular formula C17H15N5O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S62U433RMH, chemically known as 3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)-n-ethylacetanilide but generally known as zaleplon, which bears US NIH Compound Identifier 5719. European Medicines Agency schedules Zaleplon in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00132MIG. The term ZALEPLON is an International Non-Proprietary Name. World Health Organization schedules zaleplon in its Anatomical Therapeutic Chemical (ATC) Classification. ZALEPLON is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zaleplon under HS 29335995 and SITC 51576. As of Q4 2014, ZALEPLON remains the US FDA Preferred Term for this commodity. Zaleplon bears US NLM identifiers UMLS ID C0251504 and NCI Concept Code C29551. SMILES: O=C(N(C1CC(C2N3NCC(C3NCC2)C#N)CCC1)CC)C.